Incyte (INCY) Tax Provisions (2010 - 2026)
Incyte (INCY) posted Tax Provisions of $40.3 million for Q1 2026, down 55.58% on a QoQ basis from $90.7 million in Q4 2025, and down 47.0% year-over-year from $76.0 million in Q1 2025.
Incyte (INCY) Tax Provisions (2010 - 2026) Analysis & Trends
Incyte's Tax Provisions history runs 16 years deep, the most recent figure standing at $40.3 million for Q1 2026.
- Quarterly Tax Provisions fell 47.0% year-over-year to $40.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $342.1 million (up 16.6% YoY) and the FY2025 annual result came in at $377.8 million, up 33.02% from the prior year.
- Tax Provisions was $40.3 million for Q1 2026 at Incyte, down from $90.7 million in the prior quarter.
- Across five years, Tax Provisions topped out at $153.0 million in Q2 2025 and bottomed at $30.2 million in Q1 2023.
- A 5-year average of $66.3 million and a median of $62.5 million in 2023 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions jumped 206.38% — and 2026, when it slumped 47.0%.
- Incyte's Tax Provisions stood at $52.2 million in 2022, then jumped by 33.98% to $69.9 million in 2023, then surged by 61.01% to $112.5 million in 2024, then slipped by 19.42% to $90.7 million in 2025, then sank by 55.58% to $40.3 million in 2026.
- Business Quant data shows INCY's Tax Provisions at $40.3 million in Q1 2026, $90.7 million in Q4 2025, and $58.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Incyte | 23.47 Bn | 19.46 Bn | 1.17 Bn | 40.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.27 Mn |
| Dec 31, 2025 | 90.66 Mn |
| Sep 30, 2025 | 58.14 Mn |
| Jun 30, 2025 | 153.01 Mn |
| Mar 31, 2025 | 75.99 Mn |
| Dec 31, 2024 | 112.51 Mn |
| Sep 30, 2024 | 50.07 Mn |
| Jun 30, 2024 | 54.82 Mn |
| Mar 31, 2024 | 66.61 Mn |
| Dec 31, 2023 | 69.88 Mn |
| Sep 30, 2023 | 62.53 Mn |
| Jun 30, 2023 | 74.06 Mn |
| Mar 31, 2023 | 30.15 Mn |
| Dec 31, 2022 | 52.15 Mn |
| Sep 30, 2022 | 35.81 Mn |
| Jun 30, 2022 | 67.95 Mn |
| Mar 31, 2022 | 32.54 Mn |
| Dec 31, 2021 | -443.84 Mn |
| Sep 30, 2021 | 27.73 Mn |
| Jun 30, 2021 | 22.18 Mn |